Strong growth forecast for Taiwan pharmaceuticals market

26 July 2011

Taiwan has an attractive pharmaceutical market, aided by its close proximity to China, which is probably the world's most attractive emerging pharmaceutical market, says a new report from Business Monitor International.

Patented drugs account for over 60% of the total market's value - some are manufactured locally, but the majority are imported from Western Europe, the USA and Japan. The over-the-counter (OTC) sub-sector is under-developed due to widespread and generous Bureau Pof National Health Insurance (BNHI) reimbursement for patented products.

Headline expenditure projections:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical